Literature DB >> 4031453

Ancylostoma ceylanicum (Looss, 1911) in golden hamsters (Mesocricetus auratus): pathogenicity and humoral immune response to a primary infection.

S Menon, M K Bhopale.   

Abstract

The response of hamsters to Ancylostoma ceylanicum was studied between days 13 and 200 after infection. The infected hamsters showed signs of anaemia, particularly between the 13th and 60th days. A significant loss in body-weight in the infected animals was also observed during this period. Serological studies with agar gel-diffusion, counterimmunoelectrophoresis and indirect haemagglutination tests revealed positive reactions between the 20th and 60th days followed by a negative response in the latent period between the 60th and 200th days of infection, counterimmunoelectrophoresis test remained positive for a period of 150 days in this experimental model.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4031453     DOI: 10.1017/s0022149x00025724

Source DB:  PubMed          Journal:  J Helminthol        ISSN: 0022-149X            Impact factor:   2.170


  4 in total

1.  Host cytokine production, lymphoproliferation, and antibody responses during the course of Ancylostoma ceylanicum infection in the Golden Syrian hamster.

Authors:  Susana Mendez; Jesus G Valenzuela; Wenhui Wu; Peter J Hotez
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

2.  Oral transfer of adult Ancylostoma ceylanicum hookworms into permissive and nonpermissive host species.

Authors:  Richard D Bungiro; Brett R Anderson; Michael Cappello
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

3.  The genome and transcriptome of the zoonotic hookworm Ancylostoma ceylanicum identify infection-specific gene families.

Authors:  Erich M Schwarz; Yan Hu; Igor Antoshechkin; Melanie M Miller; Paul W Sternberg; Raffi V Aroian
Journal:  Nat Genet       Date:  2015-03-02       Impact factor: 38.330

4.  Improving eukaryotic genome annotation using single molecule mRNA sequencing.

Authors:  Vincent Magrini; Xin Gao; Bruce A Rosa; Sean McGrath; Xu Zhang; Kymberlie Hallsworth-Pepin; John Martin; John Hawdon; Richard K Wilson; Makedonka Mitreva
Journal:  BMC Genomics       Date:  2018-03-01       Impact factor: 3.969

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.